Katelyn is a writer with CNET covering artificial intelligence, including chatbots, image and video generators. Her work explores how new AI technology is infiltrating our lives, shaping the content ...
The FDA today unveiled a plan to accelerate development of biosimilars in hopes of significantly reducing drug costs in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback